Company / Working Capital per Share
Crinetics Pharmaceuticals, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.08
FY2025
5-year range
$5.89 / $14.16
FY2021-FY2025
Trend
-28.8%
vs FY2024
Sector context
#51 of 210
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s working capital per share of $10.08 is higher than 76% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 9 years, ranging from $5.89 in FY2022 to $4779.48 in FY2019.
Based on SEC 10-K filings.
10.08 in FY2025 with a 5-year CAGR of +7.9%. Top quartile in the Health Care sector.
Improved from $9.13 to $10.08 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +19.6%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
-93.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 28.8% year-over-year.
- Ranks #51 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.08 | -28.8% |
| FY2024 | $14.16 | +55.1% |
| FY2023 | $9.13 | +55.0% |
| FY2022 | $5.89 | -14.7% |
| FY2021 | $6.91 | +0.3% |
| FY2020 | $6.88 | -99.9% |
| FY2019 | $4779.48 | +4565.1% |
| FY2018 | $102.45 | +884.5% |
| FY2017 | $10.41 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026